Naphthylalkyl lactamimides as inhibitors of blood platelet aggregation
EM Roberts, JM Grisar, RD Mackenzie…
Index: Roberts,E.M. et al. Journal of Medicinal Chemistry, 1972 , vol. 15, # 12 p. 1270 - 1273
Full Text: HTML
Citation Number: 6
Abstract
Hexahydro-2-[1-(1-naphthyl) ethylimino] azepine. HCl (2)(RMI 7822) was found to inhibit human blood platelet aggregation induced by ADP and other agents with minimal release of procoagulant platelet factor 3. The compound was selected after careful modification of structural parameters, such as a-substitution, lactam ring size, aromatic substitution, as well as evaluation of its optical isomers.
Related Articles:
[Stanetty; Wallner Archiv der Pharmazie, 1993 , vol. 326, # 6 p. 341 - 350]
[Kuhlmey,S.-R. et al. Liebigs Annalen der Chemie, 1979 , p. 617 - 627]
[Jean, Mickael; Renaulty, Jacques; Uriac, Philippe; Capet, Marc; Van De Weghe, Pierre Organic Letters, 2007 , vol. 9, # 18 p. 3623 - 3625]
[Jean, Mickael; Renault, Jacques; Van De Weghe, Pierre Tetrahedron Letters, 2009 , vol. 50, # 47 p. 6546 - 6548]
[Vavon; Decombe Bulletin de la Societe Chimique de France, 1944 , vol. <5> 11, p. 373]